ReviewCancers2021

The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer.

Domenico Ribatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.